Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. (vol 42, pg 669, 2006)

被引：0
|
作者：
Hagan, H
Latka, MH
Campbell, JV
Golub, ET
Garfein, RS
Thomas, DA
Kapadia, F
Strathdee, SA
机构：
来源：
CLINICAL INFECTIOUS DISEASES | 2006年 / 42卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1818 / 1818
页数：1
相关论文
共 50 条
  • [1] Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities
    Hagan, H
    Latka, MH
    Campbell, JV
    Golub, ET
    Garfein, RS
    Thomas, DA
    Kapadia, F
    Strathdee, SA
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (05) : 669 - 672
  • [2] Eligibility for treatment of hepatitis C virus infection among young injection drug users in three US cities
    Hagan, H
    Campbell, J
    Garfein, R
    Latka, M
    Strathdee, S
    Thomas, D
    Golub, E
    HEPATOLOGY, 2005, 42 (04) : 693A - 693A
  • [3] Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the US
    White, Emily Faye
    Garfein, Richard S.
    Brouwer, Kimberly C.
    Lozada, Remedios
    Ramos, Rebeca
    Firestone-Cruz, Michelle
    Perez, Saida G.
    Magis-Rodriguez, Carlos
    Conde-Glez, Carlos J.
    Strathdee, Steffanie A.
    SALUD PUBLICA DE MEXICO, 2007, 49 (03): : 165 - 172
  • [4] Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities
    Murrill, CS
    Weeks, H
    Castrucci, BC
    Weinstock, HS
    Bell, BP
    Spruill, C
    Gwinn, M
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2002, 92 (03) : 385 - 387
  • [5] Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities
    Hagan, Holly
    Pouget, Enrique R.
    Williams, Ian T.
    Garfein, Richard L.
    Strathdee, Steffanie A.
    Hudson, Sharon M.
    Latka, Mary H.
    Ouellet, Lawrence J.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (03): : 378 - 385
  • [6] Treatment for hepatitis C virus infection among current injection drug users in Australia
    Matthews, G
    Kronborg, IJ
    Dore, GJ
    CLINICAL INFECTIOUS DISEASES, 2005, 40 : S325 - S329
  • [7] Prevalence and incidence of hepatitis C virus infection among young adult injection drug users
    Garfein, RS
    Doherty, MC
    Monterroso, ER
    Thomas, DL
    Nelson, KE
    Vlahov, D
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 : S11 - S19
  • [8] GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection
    Boodram, B.
    Hershow, R. C.
    Klinzman, D.
    Stapleton, J. T.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (04) : e153 - e159
  • [9] Treatment costs of hepatitis C infection among injection drug users in Canada, 2006-2026
    Werb, Daniel
    Wood, Evan
    Kerr, Thomas
    Hershfield, Neil
    Palmer, Robert W. H.
    Remis, Robert S.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2011, 22 (01) : 70 - 76
  • [10] Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment
    Thorpe, LE
    Ouellet, LJ
    Hershow, R
    Bailey, SL
    Williams, IT
    Williamson, J
    Monterroso, ER
    Garfein, RS
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (07) : 645 - 653
12345